|
FASTK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.338100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.055050E-03 |
| Normal-vs-Stage2 |
7.827400E-01 |
| Normal-vs-Stage3 |
1.539620E-02 |
| Normal-vs-Stage4 |
1.676190E-02 |
| Stage1-vs-Stage2 |
5.143300E-03 |
| Stage1-vs-Stage3 |
7.943800E-01 |
| Stage1-vs-Stage4 |
7.072200E-01 |
| Stage2-vs-Stage3 |
3.467700E-02 |
| Stage2-vs-Stage4 |
2.705900E-02 |
| Stage3-vs-Stage4 |
6.409600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.352200E-04 |
| Normal-vs-AfricanAmerican |
2.708000E-02 |
| Normal-vs-Asian |
6.200100E-03 |
| Caucasian-vs-AfricanAmerican |
8.716000E-01 |
| Caucasian-vs-Asian |
8.566400E-01 |
| AfricanAmerican-vs-Asian |
9.531600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.350200E-02 |
| Normal-vs-Female |
1.517950E-03 |
| Male-vs-Female |
3.374200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461540E-03 |
| Normal-vs-Age(41-60Yrs) |
5.243900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.079400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.754800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.798000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.528780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.951600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.980400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.238600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.389000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.462390E-01 |
| Classical-VS-Follicular |
4.8674999997278E-07 |
| Classical-VS-Other |
7.266600E-01 |
| Classical-VS-Normal |
8.48830000000911E-05 |
| Tall-VS-Follicular |
1.629690E-04 |
| Tall-VS-Other |
3.028800E-01 |
| Tall-VS-Normal |
1.350980E-04 |
| Follicular-VS-Other |
2.474200E-01 |
| Follicular-VS-Normal |
3.712800E-01 |
| Other-VS-Normal |
2.311200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.061050E-01 |
| Normal-vs-N1 |
1.299040E-01 |
| N0-vs-N1 |
5.511200E-01 |
|
|
